PubHawk
December 2016 PMID 27797291

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

Gregg W Stone, Joseph F Sabik, Patrick W Serruys, Charles A Simonton, Philippe Généreux, John Puskas, David E Kandzari, Marie-Claude Morice, Nicholas Lembo, W Morris Brown, David P Taggart, Adrian Banning, Béla Merkely, Ferenc Horkay, Piet W Boonstra

Download social card

Mentions

82
Peak: 9 in Dec 2019
across 5 sources since Dec 2019

Extended reach

61,499
potential audience

Total likes

234

Video views

7,007

Mentions per month

Dec 2019 – Mar 2021

Where it's discussed

  • News36 articles
  • Facebook27 posts
  • X / Twitter12 posts
  • Blogs6 articles
  • YouTube1 videos

AI synopsis

What people are saying

Discussions demonstrate a high level of interest and engagement, with posts referencing the EXCEL trial as a pivotal topic in cardiology, using phrases like 'scandal of the year' and sharing detailed videos, indicating that the publication stimulates in-depth debate and holds significant influence in medical communities.

AgreementModerate agreement

Most comments recognize the importance of the EXCEL trial, with some expressing support or approval of its findings, reflecting moderate agreement.

InterestHigh interest

The discussions show high engagement with the topic, as many participants are discussing specific studies, their implications, and sharing related videos, indicating strong interest.

EngagementModerate engagement

Several posts reference specific trials like the EXCEL study and mention clinical implications, suggesting thoughtful engagement rather than superficial reactions.

ImpactModerate impact

The emphasis on calling the trial 'the scandal of the year' and sharing multiple related discussions indicates the publication's perceived influence within cardiology and medical circles.

Abstract in brief

  • A study compared two treatments, drug-eluting stents (PCI) and bypass surgery (CABG), for patients with less complex left main coronary artery disease, finding that PCI was not significantly worse than CABG over three years.
  • The primary measure was a combination of death, stroke, or heart attack, with results showing similar rates between the two groups, supporting PCI as a potential alternative in certain cases.
  • Secondary outcomes and detailed analyses indicated no significant differences in major events within 30 days and at three years, though complex coronary anatomy was assessed to select appropriate candidates for each treatment.
Read the full abstract

Top posts

Most liked on X and Bluesky
Sean Shirvani MD MPH
@SeanShirvaniMD · X

Not any more as the cardiology innovators continued to push the limits of what can happen in a beating heart through a groin catheter...8/n Left main: https://t.co/txIFjCV2EF Transcatheter aortic valvular replacement: https://t.co/j0Lw40JsWl

Dec 30, 2019 · 9 likes · 1 share · 687 followers View post →
Ken Ejiri, MD, PhD 江尻健太郎
@KenEjiri · X

EXCEL trial https://t.co/q9f1njrPNs By日循サポーター #21JCS

Mar 27, 2021 · 6 likes · 2 shares · 439 followers View post →
Juan José Arango E.
@jjarangoes · X

EL ESTUDIO EXCEL, EL ESCÁNDALO DEL AÑO EN CARDIOLOGÍA es el nombre del último video que he subido a mi canal de YouTube, jjarango2. https://t.co/rxtWCK7lN5 https://t.co/te5qkZ1uny

Dec 13, 2019 · 3 likes · 1 share · 2,684 followers View post →
Juan José Arango E.
@jjarangoes · X

https://t.co/mB2iveEP8E

Dec 13, 2019 · 1 like · 2,684 followers View post →
日本循環器学会 情報広報部会
@JCIRC_IPR · X

RT @ezi_ken: EXCEL trial https://t.co/q9f1njrPNs By日循サポーター #21JCS

Mar 27, 2021 · 2 shares · 22,205 followers View post →
Takuya Kishi @ねこ好き循環器内科医
@tkishi_cardiol · X

RT @ezi_ken: EXCEL trial https://t.co/q9f1njrPNs By日循サポーター #21JCS

Mar 27, 2021 · 2 shares · 14,850 followers View post →

All mentions

日本循環器学会 情報広報部会
@JCIRC_IPR · X

RT @ezi_ken: EXCEL trial https://t.co/q9f1njrPNs By日循サポーター #21JCS

Mar 27, 2021 · 2 shares · 22,205 followers View post →
Takuya Kishi @ねこ好き循環器内科医
@tkishi_cardiol · X

RT @ezi_ken: EXCEL trial https://t.co/q9f1njrPNs By日循サポーター #21JCS

Mar 27, 2021 · 2 shares · 14,850 followers View post →
Ken Ejiri, MD, PhD 江尻健太郎
@KenEjiri · X

EXCEL trial https://t.co/q9f1njrPNs By日循サポーター #21JCS

Mar 27, 2021 · 6 likes · 2 shares · 439 followers View post →
Juan José Arango E.
@jjarangoes · X

https://t.co/k6WEACpGeV

Jan 8, 2020 · 2,684 followers View post →
RefleXion Medical
@reflexionmed · X

RT @SeanShirvaniMD: Not any more as the cardiology innovators continued to push the limits of what can happen in a beating heart through a…

Dec 30, 2019 · 1 share · 1,338 followers View post →
Sean Shirvani MD MPH
@SeanShirvaniMD · X

Not any more as the cardiology innovators continued to push the limits of what can happen in a beating heart through a groin catheter...8/n Left main: https://t.co/txIFjCV2EF Transcatheter aortic valvular replacement: https://t.co/j0Lw40JsWl

Dec 30, 2019 · 9 likes · 1 share · 687 followers View post →
RUI M S ALMEIDA
@RMSSAA · X

Great. Should be shared. https://t.co/HoulgY64iO

Dec 22, 2019 · 746 followers View post →
jhon freddy hoyos v
@cientificojhon · X

EL ESTUDIO EXCEL, EL ESCÁNDALO DEL AÑO EN CARDIOLOGÍA https://t.co/boXzjJYKAr

Dec 19, 2019 · 74 followers View post →
Joaquín Fernández, MD MSc PhD
@joaquinfdezoft · X

El Ensayo Clínico #EXCELTrial publicado en @NEJM “Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease” (NEJM) https://t.co/BxSiQvHAZu

Dec 14, 2019 · 5,999 followers View post →
Juan José Arango E.
@jjarangoes · X

https://t.co/mB2iveEP8E

Dec 13, 2019 · 1 like · 2,684 followers View post →
Anabel Vanin
@anabelvanin · X

RT @jjarangoes: EL ESTUDIO EXCEL, EL ESCÁNDALO DEL AÑO EN CARDIOLOGÍA es el nombre del último video que he subido a mi canal de YouTube, jj…

Dec 13, 2019 · 1 share · 83 followers View post →
Juan José Arango E.
@jjarangoes · X

EL ESTUDIO EXCEL, EL ESCÁNDALO DEL AÑO EN CARDIOLOGÍA es el nombre del último video que he subido a mi canal de YouTube, jjarango2. https://t.co/rxtWCK7lN5 https://t.co/te5qkZ1uny

Dec 13, 2019 · 3 likes · 1 share · 2,684 followers View post →